Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts
The Latest Bing News on:
Dana-Farber Cancer Institute Research
- New research lays foundation for targeted therapies to inhibit NF-κB activation
A new paper by Dana-Farber Cancer Institute scientists lays the foundation for targeted therapies to inhibit activation of nuclear factor kappa B (NF-κB), a transcription factor that plays a role in ...
- SAMUEL ADAMS TAPPED AS THE OFFICIAL BEER AND NON-ALCOHOLIC BEER OF THE PAN-MASS CHALLENGE
As cyclists, volunteers and spectators gear up to conquer the roads in August, Samuel Adams is excited to announce its three-year partnership with the Pan-Mass Challenge (PMC) as the official beer and ...
- Virtual, Inc. Invites Community to Support Dana-Farber Cancer Institute’s Jimmy Fund Day at Fenway Park
Virtual, Inc. continues its longstanding support for Dana-Farber Cancer Institute by sponsoring Jimmy Fund Day at Fenway, held on May 18, 2024.
- Science Retracts Paper by Dana-Farber President Over Discrepancies in Multiple Figures
The journal Science retraced a 2006 paper by Dana-Farber Cancer Institute President and CEO Laurie H. Glimcher ’72 on Thursday due to discrepancies in several figures.
- Glimcher & Lathan: Community hospitals vital to cancer care
People don’t often think about cancer care as community-based. But in Massachusetts, it is. Community-based care has been a foundation of how we treat patients at Dana-Farber Cancer Institute for ...
The Latest Bing News on:
Dana-Farber Cancer Institute Discovery
- A Closed-Loop Drug-Delivery System Could Improve Chemotherapy
New CLAUDIA system could continuously monitor patients during an infusion, adjust dosage to maintain optimal drug levels ...
- Virtual, Inc. Invites Community to Support Dana-Farber Cancer Institute’s Jimmy Fund Day at Fenway Park
Virtual, Inc. continues its longstanding support for Dana-Farber Cancer Institute by sponsoring Jimmy Fund Day at Fenway, held on May 18, 2024.
- ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Ascentage Pharma (6855.HK) is a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B, and age-related diseases. On October 28, 2019, ...
- New research suggests aspirin could aid in colorectal cancer prevention
Aspirin pills are being poured from the bottle. Study links daily aspirin use to lower colorectal cancer metastasis. NEW YORK, April 23: A recent study has unveiled a potential new dimension to ...
- Targeted therapies outperform hundreds of other drugs in 'priming' lung cancer cells for destruction
Through millions of years of evolutionary refinement, the human body has developed a sophisticated surveillance mechanism—the immune system. This intricate network is constantly scanning the body for ...